The Relationship Between Prostatic Volume And Serum Estrogen In Obese Versus Non Obese Males With Benign Prostatic Hyperplasia
DOI:
https://doi.org/10.46568/bios.v4i2-3.118Keywords:
BPH, Obesity, trans-rectal ultrasonography, Body mass index, Waist circumference, Serum estrogenAbstract
Background: Old age, obesity and androgens are more vulnerable to prostatic disorders. Benign Prostatic Hyperplasia (BPH) is a common problem for adults. Objectives: To determine the morphological changes of prostate gland and effects of Estrogen levels in obese versus non-obese males with BPH. Methods: A cross sectional study was conducted on sixty patients in an emergency clinic of Dr. Ruth Pfau, Dow university of Health Sciences, Karachi from 17th May 2019 to 15th February 2020(IRB-1182/DUHS/approval/2019). All selected patients have BPH and assessed by Global prostate side effect score >7. Patients with BPH were divided into two groups obese and non-obese, as indicated by Body Mass Index (BMI) and waist circumference (WC). Group A (obese) had BMI ≥ 25; WC ≥ 90cm and group B (non-obese) had BMI < 25; WC < 90cm. Trans rectal ultrasound and estimation of serum Estrogen was performed to analyzed the length, width, diameter and volume of prostate. Results: The mean prostate volume was higher in the obese group 36.13±3.673ml while in non-obese group it was 31.21±6.771 ml, which was found to be statistically significant (p = 0.001). The mean Estrogen levels in obese group were 328.21±115.05pmol/l, while in non-obese group it was 309.72±73.62pmol/l (p=0.462). Significant positive correlation was observed (r = 0.279, p- =0.031) between prostate volume and serum Estrogen levels in study participants. Conclusion: Obesity and serum Estrogen levels had significant effect on the prostate volume as compared to non-obese participants within same age group which showed significant moderate positive correlation with prostate volume in obesity.
References
Williams NS, Bulstrode CJ, O'connell PR. Bailey & Love's short practice of surgery: Crc Press; 2008
Raza I, Hassan N, Gul P, Jafri A, Zehra N, Younas N. Determination of prostate gland volume by ultrasonography and its correlation with anthropometric measurements in a subset of karachi population. J. adv. med. 2016: 1-12.
Chute C, Panser L, Girman C, Oesterling J, Guess H, Jacobsen S, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993; 150(1): 85-9.
Issa MM, Regan TS. Medical therapy for benign prostatic hyperplasia--present and future impact. AJMC 2007; 13: S4-9.
Lee G, Shin J, Choi H, Jo A, Pan S, Bae D, et al. Cynanchum wilfordii ameliorates testosterone-induced benign prostatic hyperplasia by regulating 5α-reductase and androgen receptor activities in a rat model. Nutrients 2017; 9(10): 1070.
Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH, et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. Eur Urol 1999; 53(3): 473-80.
Lee C-L, Kuo H-C. Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts. Tzu Chi Med. J 2017; 29(2): 79.
Xie L-P, Bai Y, Zhang X-Z, Zheng X-Y, Yao K-S, Xu L, et al. Obesity and benign prostatic enlargement: a large observational study in China. Eur Urol 2007; 69(4): 680-4.
Fujita K, Hayashi T, Matsushita M, Uemura M, Nonomura N. Obesity, inflammation, and prostate cancer. J Clin Med Res 2019; 8(2): 201.
Gómez-Ambrosi J, Silva C, Galofré J, Escalada J, Santos S, Millán D, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes 2012; 36(2): 286-94.
Kim GW, Doo SW, Yang WJ, Song YS. Effects of obesity on prostate volume and lower urinary tract symptoms in Korean men. KJ Urol 2010; 51(5): 344-7.
Lee S, Min HG, Choi SH, Kim YJ, Oh SW, Kim YJ, et al. Central obesity as a risk factor for prostatic hyperplasia. Int J Obes 2006; 14(1): 172-9.
Ajayi A, Abraham K. Understanding the role of estrogen in the development of benign prostatic hyperplasia. Afr J Urol 2018; 24(2): 93-7.
Milonas D, Matjošaitis A, Jievaltas M. Transition zone volume measurement–is it useful before surgery for benign prostatic hyperplasia? Rev Inst Med 2007; 43(10): 792.
Tirabassi G, Cignarelli A, Perrini S, Furlani G, Gallo M, Pallotti F, et al. Influence of CAG repeat polymorphism on the targets of testosterone action. Int. J. Endocrinol 2015; 2015.
Jakobsen H, Torp-Pedersen S, Juul N. Ultrasonic evaluation of age-related human prostatic growth and development of benign prostatic hyperplasia. Scand J Urol Nephrol 1988; 107: 26-31.
Raza I, Hassan N, Gul P, Jafri A, Zehra N, Younas N. Determination of Prostate Gland Volume by Ultrasonography and Its Correlation with Anthropometric Measurements in a Subset of Karachi Population. J. adv. med 2016: 1-12.
Ochiai A, Fritsche HA, Babaian RJ. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer. Eur Urol 2005; 66(4): 819-23.
Collins G, Lee R, McKelvie G, Rogers A, Hehir M. Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol 1993; 71(4): 445-50.
Fowke J, Motley S, Cookson M, Concepcion R, Chang S, Wills M, et al. The association between body size, prostate volume and prostate-specific antigen. Prostate Cancer Prostatic Dis 2007; 10(2): 137-42.
Lee RK, Chung D, Chughtai B, Te AE, Kaplan SA. Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms. BJU Int 2012; 110(4): 540-5.
Park J-H, Cho B-L, Kwon H-T, Lee C-M, Han H-J. Effect of body mass index and waist circumference on prostate specific antigen and prostate volume in a generally healthy Korean population. J Urol 2009; 182(1): 106-11.
Wallner LP, Morgenstern H, McGree ME, Jacobson DJ, Sauver JLS, Jacobsen SJ, et al. The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection. CEBP 2011; 20(3): 501-8.
Wu A, Shi Z, Martin S, Vincent A, Heilbronn L, Wittert G. Age-related changes in estradiol and longitudinal associations with fat mass in men. PloS one 2018; 13(8).
Alanazi AB, Alshalan AM, Alanazi OA, Alanazi MS, Alanazi AI, Alanazi AH, et al. Epidemiology of senile prostatic enlargement among elderly men in Arar, Kingdom of Saudi Arabia. Electronic physician 2017; 9(9): 5349.
Ng TP, Jin A, Chow KY, Feng L, Nyunt MSZ, Yap KB. Age-dependent relationships between body mass index and mortality: Singapore longitudinal ageing study. PLoS One 2017; 12(7).
Canning KL, Brown RE, Jamnik VK, Kuk JL. Relationship between obesity and obesity-related morbidities weakens with aging. J. Gerontol. A Biol 2014; 69(1): 87-92.
Koźniewski K, Wąsowski M, Jonas MI, Lisik W, Jonas M, Binda A, Jaworski P, Tarnowski W, Noszczyk B, Puzianowska-Kuźnicka M, Kuryłowicz A. Epigenetic Regulation of Estrogen Receptor Genes’ Expressions in Adipose Tissue in the Course of Obesity. International Journal of Molecular Sciences 2022 May 26; 23(11): 5989.
Zeng Q-S, Xu C-L, Liu Z-Y, Wang H-Q, Yang B, Xu W-D, et al. Relationship between serum sex hormones levels and degree of benign prostate hyperplasia in Chinese aging men. Asian J. Androl 2012; 14(5): 773.
Chin K-Y, Soelaiman I-N, Mohamed IN, Ahmad F, Ramli ESM, Aminuddin A, et al. Sex hormones in Malay and Chinese men in Malaysia: are there age and race differences? Clin 2013; 68(2): 159-66.
Bjornerem A. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromso Study. J Clin Endocrinol Metab 2004; 89: 6039-47.
Khvostova E, Otpuschennikov A, Pustylnyak V, Gulyaeva L. Gene expression of androgen metabolising enzymes in benign and malignant prostatic tissues. Horm. Metab. Res 2015; 47(02): 119-24.
Orwoll E, Lambert LC, Marshall LM, Phipps K, Blank J, Barrett-Connor E, et al. Testosterone and estradiol among older men.. J Clin Endocrinol Metab 2006; 91(4): 1336-44.
Mampa E, Haffejee M, Fru P. The correlation between obesity and prostate volume in patients with benign prostatic hyperplasia at Charlotte Maxeke Johannesburg Academic Hospital. African Journal of Urology 2021 Dec; 27: 1-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 BioSight
This work is licensed under a Creative Commons Attribution 4.0 International License.
